Equity
€123,347 ▲ 1.0%
BEMEDEX has made a profit without a break since 2018.
BEMEDEX
Lifetime
11 annual accounts with figures on one time axispeak €91,861 (2018)
€61,400▼ 33.0%
lowest -€7,920 (2017)
€1,332▼ 94.5%
peak €123,347 (2025)
€123,347▲ 1.0%
€29,860▲ 11.2%
peak 1.5 FTE (2016)
-not published
Board1 name since 2014
1 directorRUTTEN Guillaume
Documentsfilings and deeds
16-06-202645 days before the deadline
2025micro format
Gross margin from €91,610 to €61,400Result from €24,351 to €1,332Cash from €3,004 to €11,301
Key points
from the 2025 annual accountsFilings
11 annual accounts since 2015
The last five annual accounts were filed 37 to 98 days before the end of the period.
Position in the sector
80.5%
Higher solvency than 85% of companies in real estate. Sector median 28.9% · 17,190 companies.
Checked score
91
Excellent
Financially stronger than 59% of micro companies in real estate (NACE 68)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: 0.2% across 26,626 companies (NACE 68, micro).
About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.3%
01-2025: 0.3%● unchanged vs 12-2024
02-2025: 0.3%● unchanged vs 01-2025
03-2025: 0.3%● unchanged vs 02-2025
04-2025: 0.3%● unchanged vs 03-2025
05-2025: 0.4%▲ +0.1 percentage points vs 04-2025highest value
06-2025: 0.3%▼ -0.1 percentage points vs 05-2025
07-2025: 0.2%▼ -0.1 percentage points vs 06-2025
08-2025: 0.2%● unchanged vs 07-2025
09-2025: 0.2%● unchanged vs 08-2025
10-2025: 0.2%● unchanged vs 09-2025
11-2025: 0.2%● unchanged vs 10-2025
12-2025: 0.2%● unchanged vs 11-2025
01-2026: 0.2%● unchanged vs 12-2025
02-2026: 0.2%● unchanged vs 01-2026
03-2026: 0.2%● unchanged vs 02-2026
04-2026: 0.2%● unchanged vs 03-2026
05-2026: 0.2%● unchanged vs 04-2026
06-2026: 0.2%● unchanged vs 05-2026
07-2026: 0.2%● unchanged vs 06-2026
08-2026: 0.2%● unchanged vs 07-2026
09-2026: 0.2%● unchanged vs 08-2026lowest value
10-2026: 0.2%● unchanged vs 09-2026lowest value
11-2026: 0.2%● unchanged vs 10-2026lowest value
Financial strengthStrong
Score breakdown
raises risk
Size: total assets €153,207
lowers risk
Equity €123,347 (80.5% of total assets)
Founded in 2014
Figures for financial year 2025 (filed on 16-06-2026)
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 68, micro). It does better than 91% of them on solvency, 62% on liquidity, 35% on profitability and 49% on growth.
The bankruptcy probability was computed on 09-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 10,904 companies had the same profile as BEMEDEX has now. Each dot stands for 28 companies, two years later.
95.2%
were still trading
4.0%
stopped another way
0.7%
went bankrupt
That fits the bankruptcy probability of BEMEDEX itself: 0.2% within 12 months.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 10,904 companies, not a prediction for BEMEDEX. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €11,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 5.13 (5.55 in 2024), above the usual 1.5. Short-term debt is 19.5% and cash 7.4% of total assets. 19.5% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 16-06-2026, 45 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
45 days early
2024
37 days early
2023
55 days early
2022
98 days early
2021
75 days early
2020
72 days early
2019
32 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 59 days before the deadline. In the sector (NACE 68), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 7 June (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
10-11-2026 today31-12-2026 year end31-07-2027 deadline
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0506882210
Change of role: RUTTEN Guillaume, from manager to director
“Administratieve begeleiding waaronder de taken van een administratiekantoor; Bemiddelingen,in burgerlijke en…” (deed in Dutch) · Director discharge: RUTTEN Guillaume · General meeting of 20-12-2023 · Gazette deed
First establishment
EBVBA BEMEDEX, Steenkuilstraat 56, Dilsen-Stokkem
Incorporation
published on 29-12-2014 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| BEMEDEX Dilsen-Stokkem | €153,207 | €61,400 | 80.5% | - |
| EPC & VASTGOED Brasschaat | €178,530 | €53,044 | 10.4% | - |
| Expertisebureau Van de Poel & Partners Geel | €169,891 | €54,478 | 63.6% | - |
| OPTICA Vorselaar | €145,967 | €75,905 | 77.0% | - |
| Bernaerts & Palmans Ranst | €118,503 | €54,067 | 41.0% | - |
| BUREAU BERTOUIL Tournai | €206,710 | €52,733 | 69.9% | - |
| EUROHOUSE Auderghem | €132,507 | €74,436 | 44.4% | 3.6 |
These companies have the same main activity as BEMEDEX: real estate appraisal on a fee or contract basis (NACE 68322). They are comparable in size and age: total assets between €119,000 and €207,000, founded between 2011 and 2016.
Official details
Source: KBO- Status
- Active since 10-12-2014Normal situation
- Activity
- Real estate appraisal on a fee or contract basisNACE 68322and 2 others
- Establishment unit
- 2.238.488.8933650 Dilsen-Stokkem, since 16-12-2014
- Financial year end
- 31 December
- Peppol
- Reachable since 05-11-2025
Annual accounts 2025
- ≈ €130,000estimated
- €153,207▲ 2.8%
- Employeeson 31-12-2025
- 1=
- Filing
- Filed on 16-06-2026, 45 days before the end of the filing period
Insights on BEMEDEX
BEMEDEX files the micro format. That format states no turnover. The gross margin rose from €58,504 in 2015 to €61,400 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about BEMEDEX
- What is the company number of BEMEDEX?
- The company number of BEMEDEX is 0506.882.210. The VAT number is the same number with BE in front: BE 0506.882.210.
- Where is BEMEDEX based?
- The registered office is at Steenkuilstraat 56, 3650 Dilsen-Stokkem.Company details
- What does BEMEDEX do?
- According to the KBO register, the main activity is real estate appraisal on a fee or contract basis (NACE 68322).
- What is the legal form of BEMEDEX?
- BEMEDEX is a private limited company (BV).
- When was BEMEDEX founded?
- BEMEDEX was founded on 10-12-2014.
- Is BEMEDEX still active?
- Yes, BEMEDEX is an active enterprise in the KBO register.
- How many employees does BEMEDEX have?
- BEMEDEX had an average of 1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- What is the turnover of BEMEDEX?
- The turnover in financial year 2025 is ≈ €130,000. This figure is estimated from the gross margin of €61,400 and 32 comparable companies (NACE 683). It probably lies between €84,000 and €180,000.
- Is BEMEDEX profitable?
- In financial year 2025, BEMEDEX made a profit of €1,332.
- Where can I find the annual accounts of BEMEDEX?
- BEMEDEX filed 11 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of BEMEDEX due?
- BEMEDEX must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See which support similar companies received that this one did not.Subsidies Compare this company with its sector.Sector benchmark
See how customers, suppliers and banks see your own company and what to improve first.